FGF23 and chronic kidney disease: Recent epidemiologic studies have focused on the prognostic values of plasma FGF-23 levels and demonstrated that the circulating level of FGF-23 is strongly associated with higher risk of ESRD and death in subjects with CKD [13]–[17].